Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « E. Tolosa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
E. Stefanova < E. Tolosa < E. Tournier  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000087 (2015) A. Antonini [Italie] ; L. Bauer [Allemagne] ; E. Dohin [France] ; W H Oertel [Allemagne] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; M. Schmid [Allemagne] ; P. Singh [Allemagne] ; E. Tolosa [Espagne] ; K Ray Chaudhuri [Royaume-Uni]Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
000172 (2013) J. J. Ferreira [Portugal] ; R. Katzenschlager [Autriche] ; B. R. Bloem [Pays-Bas] ; U. Bonuccelli [Italie] ; D. Burn [Royaume-Uni] ; G. Deuschl [Allemagne] ; E. Dietrichs [Norvège] ; G. Fabbrini [Italie] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; V. Kostic [Serbie] ; A. Nieuwboer [Belgique] ; P. Odin [Allemagne, Suède] ; Werner Poewe [Autriche] ; O. Rascol [France] ; C. Sampaio [Portugal] ; M. Schüpbach [France, Suisse] ; E. Tolosa [Espagne] ; C. Trenkwalder [Allemagne] ; A. Schapira [Royaume-Uni] ; A. Berardelli [Italie] ; W. H. Oertel [Allemagne]Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of Parkinson's disease
000377 (2009) A. H. Schapira [Royaume-Uni] ; Yves Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; Werner Poewe [Autriche] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne]Perspectives on recent advances in the understanding and treatment of Parkinson’s disease
000431 (2007) A J Lees [Royaume-Uni] ; V. Ratziu [France] ; E. Tolosa [Espagne] ; W H Oertel [Allemagne]Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson’s disease
000461 (2006) M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; O. Rascol [France] ; C. Sampaio [Portugal]Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease
000504 (2005) Carl E. Clarke [Royaume-Uni] ; O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. Melamed [Israël] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] ; E. Tolosa [Espagne]Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study) : a randomised, double-blind, parallel-group trial. Commentary

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Human
2Parkinson disease
2Parkinson’s disease
2Treatment
2levodopa
1AEs, adverse events
1ALT, alanine aminotransferase
1AST, aspartate aminotransferase
1Adult
1Aged
1Aged, 80 and over
1Antiparkinson agent
1Apathy (drug effects)
1COMT, catechol-O-methyltransferase
1Clinical trial
1Critical study
1Dopamine Agonists (administration & dosage)
1Dopamine Agonists (adverse effects)
1Dopamine Agonists (pharmacology)
1Double blind study
1Double-Blind Method
1Female
1Fluctuations
1Humans
1Levodopa
1Male
1Medicine
1Middle Aged
1Nervous system diseases
1Outcome Assessment (Health Care)
1PD, Parkinson’s disease
1Parkinson Disease (complications)
1Parkinson Disease (drug therapy)
1Parkinson's disease
1Quality of Life
1Rasagiline
1Safety
1Tetrahydronaphthalenes (administration & dosage)
1Tetrahydronaphthalenes (adverse effects)
1Tetrahydronaphthalenes (pharmacology)
1Thiophenes (administration & dosage)
1Thiophenes (adverse effects)
1Thiophenes (pharmacology)
1Tolcapone
1Transdermal Patch
1ULN, upper limit of normal
1UPDRS, Unified Parkinson’s Disease Rating Scale
1adverse events
1autophagy
1depression
1dopamine agonist
1hepatoxicity
1liver transaminases
1management guideline
1mitochondrial
1neuroprotection
1neurosurgery
1non‐motor
1pharmacotherapy
1physiotherapy
1review
1tolcapone

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "E. Tolosa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "E. Tolosa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    E. Tolosa
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024